000201391 001__ 201391
000201391 005__ 20210129215738.0
000201391 0247_ $$2doi$$a10.1007/s00702-014-1178-2
000201391 0247_ $$2ISSN$$a0300-9564
000201391 0247_ $$2ISSN$$a1435-1463
000201391 0247_ $$2WOS$$aWOS:000338276800007
000201391 0247_ $$2altmetric$$aaltmetric:2166443
000201391 0247_ $$2pmid$$apmid:24562404
000201391 037__ $$aFZJ-2015-03686
000201391 041__ $$aEnglish
000201391 082__ $$a610
000201391 1001_ $$0P:(DE-HGF)0$$avon Papen, Mitra$$b0
000201391 245__ $$aThe effects of 1 Hz rTMS preconditioned by tDCS on gait kinematics in Parkinson’s disease
000201391 260__ $$aWien [u.a.]$$bSpringer$$c2014
000201391 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1435124562_21685
000201391 3367_ $$2DataCite$$aOutput Types/Journal article
000201391 3367_ $$00$$2EndNote$$aJournal Article
000201391 3367_ $$2BibTeX$$aARTICLE
000201391 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000201391 3367_ $$2DRIVER$$aarticle
000201391 4001_ $$aPapen, Mitra
000201391 520__ $$aHypokinetic gait is a common and very disabling symptom of Parkinson’s disease (PD). Repetitive transcranial magnetic stimulation (rTMS) over the motor cortex has been used with variable effectiveness to treat hypokinesia in PD. Preconditioning rTMS by transcranial direct current stimulation (tDCS) may enhance its effectiveness to treat hypokinetic gait in PD. Three-dimensional kinematic gait analysis was performed (1) prior to, (2) immediately after and (3) 30 min after low-frequency rTMS (1 Hz, 900 pulses, 80 % of resting motor threshold) over M1 contralateral to the more affected body side preconditioned by (1) cathodal, (2) anodal or (3) sham tDCS (amperage: 1 mA, duration: 10 min) in ten subjects with PD (7 females, mean age 63 ± 9 years) and ten healthy subjects (four females, mean age 50 ± 11 years). The effects of tDCS-preconditioned rTMS on gait kinematics were assessed by the following parameters: number of steps, step length, stride length, double support time, cadence, swing and stance phases. Our data suggest a bilateral improvement of hypokinetic gait in PD after 1 Hz rTMS over M1 of the more affected body side preceded by anodal tDCS. In contrast, 1 Hz rTMS alone (preceded by sham tDCS) and 1 Hz rTMS preceded by cathodal tDCS were ineffective to improve gait kinematics in PD. In healthy subjects, gait kinematics was unaffected by either intervention. Preconditioning motor cortex rTMS by tDCS is a promising approach to treat hypokinetic gait in PD.
000201391 536__ $$0G:(DE-HGF)POF2-333$$a333 - Pathophysiological Mechanisms of Neurological and Psychiatric Diseases (POF2-333)$$cPOF2-333$$fPOF II$$x0
000201391 588__ $$aDataset connected to CrossRef, juser.fz-juelich.de
000201391 7001_ $$0P:(DE-HGF)0$$aFisse, Mirabell$$b1
000201391 7001_ $$0P:(DE-HGF)0$$aSarfeld, Anna-Sophia$$b2
000201391 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon R.$$b3
000201391 7001_ $$0P:(DE-HGF)0$$aNowak, Dennis A.$$b4$$eCorresponding Author
000201391 773__ $$0PERI:(DE-600)1481655-6$$a10.1007/s00702-014-1178-2$$gVol. 121, no. 7, p. 743 - 754$$n7$$p743 - 754$$tJournal of neural transmission$$v121$$x1435-1463$$y2014
000201391 8564_ $$uhttps://juser.fz-juelich.de/record/201391/files/art_10.1007_s00702-014-1178-2.pdf$$yRestricted
000201391 8564_ $$uhttps://juser.fz-juelich.de/record/201391/files/art_10.1007_s00702-014-1178-2.gif?subformat=icon$$xicon$$yRestricted
000201391 8564_ $$uhttps://juser.fz-juelich.de/record/201391/files/art_10.1007_s00702-014-1178-2.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000201391 8564_ $$uhttps://juser.fz-juelich.de/record/201391/files/art_10.1007_s00702-014-1178-2.jpg?subformat=icon-180$$xicon-180$$yRestricted
000201391 8564_ $$uhttps://juser.fz-juelich.de/record/201391/files/art_10.1007_s00702-014-1178-2.jpg?subformat=icon-640$$xicon-640$$yRestricted
000201391 8564_ $$uhttps://juser.fz-juelich.de/record/201391/files/art_10.1007_s00702-014-1178-2.pdf?subformat=pdfa$$xpdfa$$yRestricted
000201391 909CO $$ooai:juser.fz-juelich.de:201391$$pVDB
000201391 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000201391 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000201391 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000201391 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000201391 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000201391 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000201391 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000201391 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000201391 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000201391 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000201391 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF <  5
000201391 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich GmbH$$b3$$kFZJ
000201391 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-HGF)0$$aForschungszentrum Jülich GmbH$$b4$$kFZJ
000201391 9132_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000201391 9131_ $$0G:(DE-HGF)POF2-333$$1G:(DE-HGF)POF2-330$$2G:(DE-HGF)POF2-300$$3G:(DE-HGF)POF2$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lFunktion und Dysfunktion des Nervensystems$$vPathophysiological Mechanisms of Neurological and Psychiatric Diseases$$x0
000201391 9141_ $$y2015
000201391 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000201391 980__ $$ajournal
000201391 980__ $$aVDB
000201391 980__ $$aI:(DE-Juel1)INM-3-20090406
000201391 980__ $$aUNRESTRICTED